Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 984 entries
View as:

A Study of Soticlestat Tablets in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05284760 Org: User:
Start: 03/11/22 End: 06/02/22 Due: 06/02/23

TAK-114 Single- and Multiple-Dose Phase 1 Study

Phase: N/A Priority: Normal
NCT ID: NCT02286518 Org: User:
Start: 11/30/14 End: 04/30/15 Due: 04/30/16

Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00727857 Org: User:
Start: 06/30/07 End: 08/31/08 Due: 08/31/09

Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01916304 Org: User:
Start: 07/31/13 End: 06/30/14 Due: 06/30/15

A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00220818 Org: User:
Start: 01/31/05 End: 07/31/05 Due: 07/31/06

MPC-004 for the Treatment of an Acute Gout Flare

Phase: N/A Priority: Normal
NCT ID: NCT00506883 Org: User:
Start: 04/30/07 End: 10/31/07 Due: 10/31/08

TAK-438 - Safety, Blood Levels & Effects of Repeated Doses

Phase: N/A Priority: Normal
NCT ID: NCT02141711 Org: User:
Start: 10/31/08 End: 02/28/09 Due: 02/28/10

A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT02655237 Org: User:
Start: 03/05/16 End: 09/25/17 Due: 09/25/18

A Study of TAK-105 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04964258 Org: User:
Start: 07/26/21 End: 06/20/23 Due: 06/20/24

Study of Combination Therapy With SYR-322

Phase: N/A Priority: Normal
NCT ID: NCT01521962 Org: User:
Start: 02/29/12 End: 03/31/13 Due: 03/31/14

Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity

Phase: N/A Priority: Normal
NCT ID: NCT01728792 Org: User:
Start: 01/22/13 End: 11/21/13 Due: 11/21/14

Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02203916 Org: User:
Start: 07/31/14 End: 02/29/16 Due: 02/28/17

Study to Evaluate Absorption, Metabolism, and Excretion, of TAK-994 in 6 Healthy Male Adults

Phase: N/A Priority: Normal
NCT ID: NCT04833049 Org: User:
Start: 04/14/21 End: 06/20/21 Due: 06/20/22

Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02743806 Org: User:
Start: 08/01/16 End: 01/03/23 Due: 01/03/24

A Study of Soticlestat and Rifampin in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05098041 Org: User:
Start: 11/22/21 End: 03/03/22 Due: 03/03/23

A Phase 1, Single and Multiple Dose Study of TAK-137

Phase: N/A Priority: Normal
NCT ID: NCT02322606 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00772174 Org: User:
Start: 01/31/07 End: 02/29/08 Due: 02/28/09

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT04096560 Org: User:
Start: 05/27/20 End: 11/05/21 Due: 11/05/22

A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation

Phase: N/A Priority: Normal
NCT ID: NCT03434977 Org: User:
Start: 02/14/18 End: 03/11/18 Due: 03/11/19

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)

Phase: N/A Priority: Normal
NCT ID: NCT02176486 Org: User:
Start: 06/09/14 End: 01/19/18 Due: 01/19/19

A Bioequivalence Study of TAK-536 Pediatric Formulation

Phase: N/A Priority: Normal
NCT ID: NCT02401464 Org: User:
Start: 03/31/15 End: 05/31/15 Due: 05/31/16

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT02209506 Org: User:
Start: 07/31/14 End: 12/31/14 Due: 12/31/15

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01263470 Org: User:
Start: 01/31/07 End: 12/31/07 Due: 12/31/08

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00487994 Org: User:
Start: 11/30/04 End: 05/31/07 Due: 05/31/08

Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT03116841 Org: User:
Start: 08/02/17 End: 12/20/17 Due: 12/20/18